WU JAY DONOVAN enters ASCENDIS PHARMA A/S with 1.07K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001610717-26-000110
Officer· EVP & President US Market
Since Mar 2026
1.07K
Baseline shares
100% direct
1.07K
Direct ownership
1 position
57.96K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned1.07K
Total
1.07K direct1.07K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 1.07K | Direct |
| Total | 1.07K | 1.07K direct |
Derivative Holdings3
Warrants
DirectUnderlying security
Ordinary Shares
Underlying shares
45.08K
Shares owned
N/A
Exercise price
131.57
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Ordinary Shares
Underlying shares
3.33K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Ordinary Shares
Underlying shares
9.55K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
57.96K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Direct | Ordinary Shares | 131.57 | — | — | 45.08K | N/A |
| Restricted Stock Units Direct | Ordinary Shares | — | — | 3.33K | N/A | |
| Restricted Stock Units Direct | Ordinary Shares | — | — | 9.55K | N/A | |
| Total | 57.96K | 0.00 | ||||